Ipsen Group - Company & Market Research Reports

Home /
Companies /
Ipsen Group

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 77
Central Nervous System Drugs 60
Endocrine and Metabolic Disorders Drugs 46
Drug Discovery 32
Infusions and Injectables 25
Musculoskeletal Disorders Drugs 24
Surgical Procedures 20
Pharmaceuticals 17
Biopharmaceuticals 15
Prostate Cancer Drugs 12
Clinical Trials 12
Drug Delivery 11
Liver Cancer Drugs 10
Women's Health 10
Neurology 9
Dermatology 9
Pancreatic Cancer Drugs 9
Lung Cancer Drugs 8
Biotechnology 7
Healthcare Services 7
Immune Disorders Drugs 7
Medical Devices 7
Breast Cancer Drugs 6
Diagnostics 6
Gastrointestinal Drugs 6
Liver and Kidney Disorders Drugs 6
Thyroid Cancer Drugs 6
Company Reports 5
Ovarian Cancer Drugs 5
Oncology 5
Dermatological Drugs 5
Sexual and Reproductive Health Drugs 5
Urology and Nephrology 4
Brain Cancer Drugs 4
Bladder Cancer Drugs 4
Genomics 4
Enzymes 4
Over the Counter (OTC) Drugs 4
Therapeutic Area 3
Drugs by Therapeutic Area 3
Cardiovascular Drugs 3
Colon Cancer Drugs 3
Managed Care 3
Kidney Cancer Drugs 3
Pediatrics 3
Gastroenterology 3
Optical Disorders Drugs 2
Lymphoma Drugs 2
In Vitro Diagnostics 2
Healthcare 2
Diabetes Devices 2
Needles and Syringes 2
Surgical Devices 2
Biosimilars and Biosuperiors 2
Skin Cancer Drugs 2
Nanomedicine 2
Urological Disorders Drugs 2
Pharmaceutical Manufacturing 2
Pharmaceutical Intermediates 1
Allergy and Immunology 1
Infectious Diseases Drugs 1
Leukemia Drugs 1
Cervical Cancer Drugs 1
Point-of-Care Diagnostics 1
Infectious Disease Testing 1
Analgesics 1
Transdermal and Transmucosal Drug Delivery 1
Biomaterials 1
Hematology 1
Hematological Drugs 1
Nuclear Medicine and Radiopharmacology 1
Other Healthcare Facilities 1
Laboratory Equipment 1
Anti-Obesity Drugs 1
Intensive Care and Emergency Medicine 1
Alzheimer's Disease Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

419 Results (Page 3 of 21)
- Relevance
  Sort by

Pancreatic Endocrine Tumor - Pipeline Insight, 2024

 Clinical Trials
April 2024
60 Pages
Global

From

€1382EUR$1,400USD£1,154GBP

€1975EUR$2,000USD£1,649GBP

Biliary Tract Cancer (BTC) - Pipeline Insight, 2024

 Clinical Trials
April 2024
180 Pages
Global

From

€2074EUR$2,100USD£1,732GBP

€2962EUR$3,000USD£2,474GBP

Botulinum Toxin & HA Dermal Filler Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

 Report
May 2023
74 Pages
Global

From

€3500EUR$3,797USD£3,025GBP

Somatostatin Analog Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
77 Pages
Global

From

€3500EUR$3,797USD£3,025GBP

Chronic Lower Back Pain Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Pediatric Growth Hormone Deficiency Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

 Report
October 2023
175 Pages
Global

From

€4443EUR$4,500USD£3,710GBP

Global Neurotoxin Market Forecast to 2028 - Analysis by Product Type, Application, and End-user

 Report
May 2023
186 Pages
Global

From

€3145EUR$3,185USD£2,626GBP

€4493EUR$4,550USD£3,752GBP

Neurotoxin Market Forecast to 2028 - Global Analysis By Product Type, Application, and End User

 Report
May 2023
186 Pages
Global

From

€3145EUR$3,185USD£2,626GBP

€4493EUR$4,550USD£3,752GBP

Collaboration Deals in Pharmaceuticals 2019-2024

 Report
September 2024
1150 Pages
Global

From

€3945EUR$3,995USD£3,294GBP

Licensing Deals in Pharmaceuticals 2019-2024

 Report
September 2024
1400 Pages
Global

From

€3945EUR$3,995USD£3,294GBP

Endometriosis Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Endometriosis Type, By Diagnostic Method, By Treatment Method, By Drug Category, By Diagnostics Type, By Distribution Channel, By End-User, Company, Region

 Report
November 2022
111 Pages
Global

From

€4443EUR$4,500USD£3,710GBP

Consumer Healthcare Market by Product, Distribution - Global Forecast 2025-2030

 Report
October 2024
195 Pages
Global

From

€3501EUR$3,545USD£2,923GBP

€3890EUR$3,939USD£3,248GBP

Paediatric Healthcare Market by Treatment, Indication, End-User - Global Forecast 2025-2030

 Report
October 2024
186 Pages
Global

From

€3501EUR$3,545USD£2,923GBP

€3890EUR$3,939USD£3,248GBP

Neurotoxin Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Pituitary Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

 Report
October 2023
175 Pages
Global

From

€4443EUR$4,500USD£3,710GBP

Esophageal Cancer Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Prostate Health Market by Disease Type, Therapy Type, Drug Treatment Type - Global Forecast 2025-2030

 Report
October 2024
198 Pages
Global

From

€3501EUR$3,545USD£2,923GBP

€3890EUR$3,939USD£3,248GBP

Triptorelin acetate Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
April 2023
86 Pages
Global

From

€3500EUR$3,797USD£3,025GBP

Pancreatic Endocrine Tumor Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
89 Pages
Global

From

€3500EUR$3,797USD£3,025GBP

Gynecological Cancer Drugs Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

419 Results (Page 3 of 21)
- 1
- 2
- 3
- 4
- 5

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.